These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S. Am J Clin Oncol; 2009 Dec 15; 32(6):574-81. PubMed ID: 19636238 [Abstract] [Full Text] [Related]
5. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer]. Zhao Y, Wang SM, Zhang J. Ai Zheng; 2002 Apr 15; 21(4):421-3. PubMed ID: 12452025 [Abstract] [Full Text] [Related]
6. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. Ho AS, Picus J, Darcy MD, Tan B, Gould JE, Pilgram TK, Brown DB. AJR Am J Roentgenol; 2007 May 15; 188(5):1201-7. PubMed ID: 17449759 [Abstract] [Full Text] [Related]
7. [Infusion chemotherapy and chemoembolization of liver metastases from cancer of the alimentary tract]. Zeng H, Li H, Shi Z. Zhonghua Zhong Liu Za Zhi; 2000 Sep 15; 22(5):422-4. PubMed ID: 11778283 [Abstract] [Full Text] [Related]
8. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. Ruutiainen AT, Soulen MC, Tuite CM, Clark TW, Mondschein JI, Stavropoulos SW, Trerotola SO. J Vasc Interv Radiol; 2007 Jul 15; 18(7):847-55. PubMed ID: 17609443 [Abstract] [Full Text] [Related]
9. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, Benson AB, Rao S, Joehl RJ. Surgery; 2001 Oct 15; 130(4):677-82; discussion 682-5. PubMed ID: 11602899 [Abstract] [Full Text] [Related]
10. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience. Dejong CH, Parks RW, Currie E, Piris J, Redhead DN, Garden OJ. J R Coll Surg Edinb; 2002 Apr 15; 47(2):495-9. PubMed ID: 12018694 [Abstract] [Full Text] [Related]
11. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver. Chung MH, Pisegna J, Spirt M, Giuliano AE, Ye W, Ramming KP, Bilchik AJ. Surgery; 2001 Dec 15; 130(6):954-62. PubMed ID: 11742323 [Abstract] [Full Text] [Related]
12. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. di Bartolomeo M, Bajetta E, Buzzoni R, Mariani L, Carnaghi C, Somma L, Zilembo N, di Leo A. Cancer; 1996 Jan 15; 77(2):402-8. PubMed ID: 8625251 [Abstract] [Full Text] [Related]